Objective To determine the accuracy of salivary gland ultrasonography (SGUS) for
diagnosing primary Sjögren's syndrome (SS) and to suggest modifications of the American–European …

Objectives The predominance of extramuscular manifestations (eg, skin rash, arthralgia,
interstitial lung disease [ILD]) as well as the low frequency of muscle signs in anti–melanoma …

Importance Few treatments are available for patients with glucocorticoid-dependent
polymyalgia rheumatica. IL-6 antagonists may reduce disease activity in patients with active …

OBJECTIVES: To assess the diagnostic value of minor salivary gland biopsy (MSGB) for
primary Sjögren's syndrome (pSS). METHODS: Systematic review of studies retrieved from …

Objective. The aim of this study was to evaluate whether salivary gland ultrasonography (SGUS)
improves the diagnostic performance of the 2012 ACR classification criteria for SS. …

Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR)
but induce adverse events. Objectives To evaluate the efficacy and safety of first-line …

Objective To evaluate changes in salivary gland echostructure and vascularization after
rituximab treatment in patients with primary Sjögren's syndrome (SS). Methods Twenty‐eight …

Background The objective was to evaluate concordance between 2002 American-European
Consensus Group (AECG) and 2016 American College of Rheumatology (ACR)/European …

Objective To compare quality of life (QoL), depression, anxiety, and fatigue in prospectively
included patients with primary Sjögren's syndrome (pSS) or with sicca but no diagnosis of …

Objectives. To evaluate the reproducibility of clinical synovitis assessments in rheumatoid
arthritis and the effect of variability on the Disease Activity Score-28 (DAS28). Methods. Seven …